BCL7A and primary cutaneous T-cell non-Hodgkin lymphoma: In addition, BCL7A was found to be highly methylated in patients with cutaneous T-cell lymphoma and was identified as a marker of a poor prognosis in early-stage cutaneous T-cell lymphoma patients [8].